To initiate a Belviq lawsuit, it is imperative that you consult our team of attorneys who specialize in Belviq cases. Firstly, they will diligently review your case and evaluate your eligibility for compensation. Additionally, they will provide ongoing representation throughout the legal proceedings. Moreover, our dedicated team will file a lawsuit on your behalf, seeking reimbursement for medical expenses, lost wages, emotional distress, and other damages resulting from your cancer diagnosis.
What is Belviq?
Belviq (lorcaserin) is a prescription medication for weight loss in obese or overweight individuals. It affects the brain’s chemical signals to control appetite. Belviq is not suitable for everyone and should not be used with other weight loss drugs or herbal supplements. The FDA approved the drug in 2012, and millions of Americans have used it since then.
What is the Belviq Lawsuit?
Belviq users diagnosed with certain types of cancer may qualify to file a lawsuit against Eisai Inc. and seek compensation for medical expenses, lost wages, and pain and suffering. The lawsuit claims that Eisai Inc. was aware of or should have been aware of the potential cancer risks linked to Belviq and failed to warn consumers sufficiently.
Why was Belviq recalled?
The link between Belviq and cancer has raised concerns for years. In January 2020, the FDA requested Belviq’s withdrawal from the market due to increased cancer risk. Pancreatic, colorectal, and lung cancer showed higher incidence in patients using Belviq. Lawsuits have been filed by individuals who developed cancer within seven years of taking Belviq.
The FDA withdrew Belviq due to a five-year study assessing the drug’s cardiovascular effects, which also revealed a potential link to cancer. The active ingredient, Lorcaserin, posed greater risks than benefits, prompting necessary action to safeguard public health.
The study involved 12,000 participants who were either taking Belviq or a placebo. Interestingly, it was found that 7.7% of Belviq users developed cancer, compared to 7.1% in the placebo group. Specifically, the lawsuit cites pancreatic, colorectal, and lung cancer concerns.
It’s worth noting that Eisai Inc., the manufacturer, and marketer of Belviq, claimed that their independent study showed different results. However, ultimately, they complied with the FDA’s recommendation to withdraw the drug, thus validating the agency’s concern regarding the risk of cancer from this medication.
How can you take legal action?
Our skilled attorneys at Gallon, Takacs, & Boissoneault meticulously review medical records. They provide expert guidance on case viability and assist with navigating the complex legal procedures of filing a Belviq lawsuit. If you have been diagnosed with pancreatic cancer, colorectal cancer, lung cancer, or kidney cancer after taking Belviq, you are entitled to fair compensation for physical, emotional, and financial adversities endured. Our firm specializes in assessing eligibility, pursuing legal action against Belviq manufacturers, and delivering the justice you deserve.
To explore your options and take the first step towards attaining justice, don’t hesitate to contact us today at 419-843-6663 or complete a free case evaluation form.
